Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT05826158
Overview
This is a study evaluating the positron-emitting radiopharmaceutical 18F-mFBG compared to 123I-mIBG scintigraphy for imaging of neuroblastoma
Sponsor
Rigshospitalet
Phase
N/A
Contacts
Lise Borgwardt, MD, PhD. (Principal Investigator)
lise.borgwardt@regionh.dk
+4535459568
ClinicalTrials.gov
NCT05826158Help us improve your experience